QQQ $ 495.80 $ 5.12 (1.04 %)
DIA $ 393.71 $ 0.87 (0.22 %)
SPY $ 554.29 $ 3.18 (0.58 %)
TLT $ 92.56 $ 0.76 (0.83 %)
GLD $ 220.89 $ 2.94 (1.35 %)
$ na
-- x --
-- x --
-- - --
na - na
0
na
na
na
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

 CRH Medical Corporation (TSX:CRH) (NYSE:CRHM) ("CRH" or the "Company") announced today that it has filed with ...

Core News & Articles

CRH Medical Corporation ("CRH", or the "Company") (TSX:CRH) (NYSE:CRHM) announces that it has completed an accr...

Core News & Articles

CRH Medical Corporation Common Shares of Beneficial Interest (AMEX:CRHM) reported $36.78 million in sales this quarter. This is...

Core News & Articles

CRH Medical Corporation ("CRH", or the "Company") (TSX:CRH) (NYSE:CRHM) today announces a startup joint venture...

Core News & Articles

CRH Signs New Agreement with United Digestive VANCOUVER, BC, Feb. 23, 2021 /CNW/ - CRH Medical Corporation ("CRH", or ...

Core News & Articles

RBC Capital analyst Douglas Miehm downgrades CRH Medical (TSX:CRH) from Outperform to Sector Perform and announces C$5 price...

Core News & Articles

Canaccord Genuity analyst Richard Close downgrades CRH Medical (TSX:CRH) from Buy to Hold and announces C$5.1 price target.

Core News & Articles

VANCOUVER, BC, Nov. 19, 2020 /CNW/ - CRH Medical Corporation (the "Company") (TSX:CRH) (NYSE:CRHM), announces that it h...

Core News & Articles

Second quarter 2020 highlights: Total revenue of $13.6 million, down 55.4% from second quarter 2019 Anesthesia services rev...

Core News & Articles

VANCOUVER, BC, July 7, 2020 /CNW/ - CRH Medical Corporation ("CRH", or the "Company") (TSX:CRH) (NYSE:CRHM), an...